Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 95

1.

Disseminated carcinomatosisof the bone marrow associated with bone marrow metastasis of hepatocellular carcinoma. A case report.

Honda Y, Kawaoka T, Aikata H, Kan H, Fujino H, Kobayashi T, Fukuhara T, Naeshiro N, Hiramatsu A, Imamura M, Kawakami Y, Hyogo H, Arihiro K, Chayama K.

Hepatol Res. 2014 Jul 17. doi: 10.1111/hepr.12391. [Epub ahead of print]

PMID:
25041322
[PubMed - as supplied by publisher]
2.

Insulin Resistance Correlated With the Severity of Liver Histology in Japanese NAFLD Patients: A Multicenter Retrospective Study.

Kessoku T, Yoneda M, Sumida Y, Eguchi Y, Fujii H, Hyogo H, Ono M, Kawaguchi T, Nakajima A; Japan Study Group of NAFLD (JSG-NAFLD).

J Clin Gastroenterol. 2014 Jul 10. [Epub ahead of print] No abstract available.

PMID:
25014241
[PubMed - as supplied by publisher]
3.

Eicosapentaenoic acid/arachidonic acid ratio as a possible link between non-alcoholic fatty liver disease and cardiovascular disease.

Ishitobi T, Hyogo H, Kan H, Hiramatsu A, Arihiro K, Aikata H, Chayama K.

Hepatol Res. 2014 Jun 30. doi: 10.1111/hepr.12382. [Epub ahead of print]

PMID:
24976364
[PubMed - as supplied by publisher]
4.

Efficacy and safety of sitagliptin for the treatment of nonalcoholic fatty liver disease with type 2 diabetes mellitus.

Fukuhara T, Hyogo H, Ochi H, Fujino H, Kan H, Naeshiro N, Honda Y, Miyaki D, Kawaoka T, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Aikata H, Chayama K.

Hepatogastroenterology. 2014 Mar-Apr;61(130):323-8.

PMID:
24901133
[PubMed - indexed for MEDLINE]
5.

Modification of a simple clinical scoring system as a diagnostic screening tool for non-alcoholic steatohepatitis in Japanese patients with non-alcoholic fatty liver disease.

Nakamura A, Yoneda M, Sumida Y, Eguchi Y, Fujii H, Hyogo H, Ono M, Suzuki Y, Kawaguchi T, Aoki N, Okanoue T, Nakajima A, Maeda S, Terauchi Y.

J Diabetes Investig. 2013 Nov 27;4(6):651-8. doi: 10.1111/jdi.12101. Epub 2013 May 19.

PMID:
24843721
[PubMed]
Free PMC Article
6.

Uric acid levels decrease with fibrosis progression in patients with nonalcoholic fatty liver disease.

Yoneda M, Thomas E, Sumida Y, Imajo K, Hyogo H, Fujii H, Ono M, Kawaguchi T, Eguchi Y, Nakajima A.

Clin Biochem. 2014 May 4. pii: S0009-9120(14)00216-1. doi: 10.1016/j.clinbiochem.2014.04.026. [Epub ahead of print] No abstract available.

PMID:
24797484
[PubMed - as supplied by publisher]
7.

Pilot study of liraglutide effects in non-alcoholic steatohepatitis and non-alcoholic fatty liver disease with glucose intolerance in Japanese patients (LEAN-J).

Eguchi Y, Kitajima Y, Hyogo H, Takahashi H, Kojima M, Ono M, Araki N, Tanaka K, Yamaguchi M, Matsuda Y, Ide Y, Otsuka T, Ozaki I, Ono N, Eguchi T, Anzai K; Japan Study Group for NAFLD (JSG-NAFLD).

Hepatol Res. 2014 May 4. doi: 10.1111/hepr.12351. [Epub ahead of print]

PMID:
24796231
[PubMed - as supplied by publisher]
8.

Association of polymorphisms in GCKR and TRIB1 with nonalcoholic fatty liver disease and metabolic syndrome traits.

Kitamoto A, Kitamoto T, Nakamura T, Ogawa Y, Yoneda M, Hyogo H, Ochi H, Mizusawa S, Ueno T, Nakao K, Sekine A, Chayama K, Nakajima A, Hotta K.

Endocr J. 2014 May 1. [Epub ahead of print]

PMID:
24785259
[PubMed - as supplied by publisher]
Free Article
9.

Non-invasive assessment of liver steatosis in non-alcoholic fatty liver disease.

Kan H, Kimura Y, Hyogo H, Fukuhara T, Fujino H, Naeshiro N, Honda Y, Kawaoka T, Tsuge M, Hiramatsu A, Imamura M, Kawakami Y, Aikata H, Ochi H, Arihiro K, Chayama K.

Hepatol Res. 2014 Mar 18. doi: 10.1111/hepr.12330. [Epub ahead of print]

PMID:
24636073
[PubMed - as supplied by publisher]
10.

Clinical Usage of Serum Ferritin to Assess Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease: Proceed with Caution.

Yoneda M, Thomas E, Sumida Y, Imajo K, Eguchi Y, Hyogo H, Fujii H, Ono M, Kawaguchi T, Schiff ER.

Hepatol Res. 2014 Mar 14. doi: 10.1111/hepr.12327. [Epub ahead of print]

PMID:
24628717
[PubMed - as supplied by publisher]
11.

Targeted next-generation sequencing and fine linkage disequilibrium mapping reveals association of PNPLA3 and PARVB with the severity of nonalcoholic fatty liver disease.

Kitamoto T, Kitamoto A, Yoneda M, Hyogo H, Ochi H, Mizusawa S, Ueno T, Nakao K, Sekine A, Chayama K, Nakajima A, Hotta K.

J Hum Genet. 2014 May;59(5):241-6. doi: 10.1038/jhg.2014.17. Epub 2014 Mar 13.

PMID:
24621583
[PubMed - in process]
12.

Clinical outcome and prognostic factors of patients with hepatocellular carcinoma and extrahepatic metastasis treated with sorafenib.

Kawaoka T, Aikata H, Kan H, Fujino H, Fukuhara T, Kobayashi T, Naeshiro N, Miyaki D, Hiramatsu A, Imamura M, Kawakami Y, Hyogo H, Chayama K.

Hepatol Res. 2014 Feb 8. doi: 10.1111/hepr.12307. [Epub ahead of print]

PMID:
24506236
[PubMed - as supplied by publisher]
13.

[Progress in treatment and study of NAFLD. Discussion].

Shiota G, Uto H, Ono M, Tokushige K, Sumida Y, Hyogo H.

Nihon Shokakibyo Gakkai Zasshi. 2014 Jan;111(1):42-60. Japanese. No abstract available.

PMID:
24390258
[PubMed - indexed for MEDLINE]
14.

Upper limit of normal serum alanine aminotransferase levels in Japanese subjects.

Tanaka K, Hyogo H, Ono M, Takahashi H, Kitajima Y, Ono N, Eguchi T, Fujimoto K, Chayama K, Saibara T, Anzai K, Eguchi Y; the Japan Study Group of Non-alcoholic Fatty Liver Disease (JSG-NAFLD).

Hepatol Res. 2013 Dec 23. doi: 10.1111/hepr.12293. [Epub ahead of print]

PMID:
24372862
[PubMed - as supplied by publisher]
15.

Long-term outcome of patients with gastric varices treated by balloon-occluded retrograde transvenous obliteration.

Naeshiro N, Aikata H, Kakizawa H, Hyogo H, Kan H, Fujino H, Kobayashi T, Fukuhara T, Honda Y, Ohno A, Miyaki D, Kawaoka T, Tsuge M, Hiraga N, Hiramatsu A, Imamura M, Kawakami Y, Takahashi S, Awai K, Chayama K.

J Gastroenterol Hepatol. 2014 May;29(5):1035-42. doi: 10.1111/jgh.12508.

PMID:
24372807
[PubMed - in process]
16.

Predictive value of the IFNL4 polymorphism on outcome of telaprevir, peginterferon, and ribavirin therapy for older patients with genotype 1b chronic hepatitis C.

Fujino H, Imamura M, Nagaoki Y, Kawakami Y, Abe H, Hayes CN, Kan H, Fukuhara T, Kobayashi T, Masaki K, Ono A, Nakahara T, Honda Y, Naeshiro N, Urabe A, Yokoyama S, Miyaki D, Murakami E, Kawaoka T, Hiraga N, Tsuge M, Hiramatsu A, Hyogo H, Aikata H, Takahashi S, Miki D, Ochi H, Ohishi W, Chayama K; Hiroshima Liver Study Group.

J Gastroenterol. 2013 Dec 21. [Epub ahead of print]

PMID:
24362944
[PubMed - as supplied by publisher]
17.

Type 2 diabetes mellitus is associated with the fibrosis severity in patients with nonalcoholic fatty liver disease in a large retrospective cohort of Japanese patients.

Nakahara T, Hyogo H, Yoneda M, Sumida Y, Eguchi Y, Fujii H, Ono M, Kawaguchi T, Imajo K, Aikata H, Tanaka S, Kanemasa K, Fujimoto K, Anzai K, Saibara T, Sata M, Nakajima A, Itoh Y, Chayama K, Okanoue T; Japan Study Group of Nonalcoholic Fatty Liver Disease (JSG-NAFLD).

J Gastroenterol. 2013 Nov 26. [Epub ahead of print]

PMID:
24277052
[PubMed - as supplied by publisher]
18.

Glycemic variability is an independent predictive factor for development of hepatic fibrosis in nonalcoholic fatty liver disease.

Hashiba M, Ono M, Hyogo H, Ikeda Y, Masuda K, Yoshioka R, Ishikawa Y, Nagata Y, Munekage K, Ochi T, Hirose A, Nozaki-Fujimura Y, Noguchi S, Okamoto N, Chayama K, Suganuma N, Saibara T.

PLoS One. 2013 Nov 6;8(11):e76161. doi: 10.1371/journal.pone.0076161. eCollection 2013.

PMID:
24223115
[PubMed - in process]
Free PMC Article
19.

Rodent models of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis.

Imajo K, Yoneda M, Kessoku T, Ogawa Y, Maeda S, Sumida Y, Hyogo H, Eguchi Y, Wada K, Nakajima A.

Int J Mol Sci. 2013 Nov 4;14(11):21833-57. doi: 10.3390/ijms141121833. Review.

PMID:
24192824
[PubMed - indexed for MEDLINE]
Free PMC Article
20.

The association of insomnia with gastroesophageal reflux symptoms in biopsy-proven nonalcoholic fatty liver disease.

Taketani H, Sumida Y, Tanaka S, Imajo K, Yoneda M, Hyogo H, Ono M, Fujii H, Eguchi Y, Kanemasa K, Chayama K, Itoh Y, Yoshikawa T, Saibara T, Fujimoto K, Nakajima A; Japan Study Group of NAFLD (JSG-NAFLD).

J Gastroenterol. 2014 Jul;49(7):1163-74. doi: 10.1007/s00535-013-0871-5. Epub 2013 Aug 22.

PMID:
23975270
[PubMed - in process]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk